Biotech IPOs in Hong Kong far outpace the US, driven by China’s buzzy biotech sectornews2025-10-02T14:39:04+00:00October 2nd, 2025|Endpoints News|
Amgen’s cholesterol-lowering shot could get sales boost from CV trial successnews2025-10-02T13:00:40+00:00October 2nd, 2025|Endpoints News|
Koda Health raises $7M for advanced care planning softwarenews2025-10-02T13:00:18+00:00October 2nd, 2025|Endpoints News|
Roche was the only pharma to make an acquisition offer for 89bionews2025-10-02T12:41:57+00:00October 2nd, 2025|Endpoints News|
A year after collaborating with Gilead, Cartography maps out its own Phase 1 with $67M Series Bnews2025-10-02T11:30:35+00:00October 2nd, 2025|Endpoints News|
Gene therapy startup launches with $11M to tackle aging disease of the eyenews2025-10-02T11:00:20+00:00October 2nd, 2025|Endpoints News|
Takeda lays off 137 workers following cell therapy stoppagenews2025-10-02T08:54:55+00:00October 2nd, 2025|Endpoints News|
Galapagos says it’s weeks away from decision on cell therapy business reviewnews2025-10-02T01:59:11+00:00October 2nd, 2025|Endpoints News|
Exclusive: Upcoming ACIP meeting may move to Decembernews2025-10-01T21:25:13+00:00October 1st, 2025|Endpoints News|
Third-round IRA guidance spells out new orphan drug protectionsnews2025-10-01T20:00:21+00:00October 1st, 2025|Endpoints News|
